Pneumolysin (4.18 ng/ml)-mediated influx of Ca2؉ and augmentation of the chemoattractant-activated generation of reactive oxidants was antagonized by pretreatment of human neutrophils with the omega-3 polyunsaturated fatty acids docosahexaenoic acid and eicosapentaenoic acid (1.25 to 5 g/ml). These agents may have potential in attenuating the proinflammatory properties of this pneumococcal toxin.Notwithstanding complement-activating properties, poreforming interactions with neutrophils and monocytes, resulting in influx of Ca 2ϩ , have been implicated in the proinflammatory activities of the pneumococcal toxin, pneumolysin (1,2,3,4,11). Rather than contributing to the eradication of the infection, however, the resultant, predominantly neutrophil-mediated inflammatory response appears to favor persistence and extrapulmonary dissemination of the pneumococcus (7, 9).Although no pharmacological antagonists of pneumolysin have, to our knowledge, been described, we reasoned that agents, such as the omega-3 polyunsaturated fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), which increase neutrophil membrane fluidity and stability may interfere with the proinflammatory, pore-forming activities of the toxin. The present study was designed to investigate the potential of DHA and EPA to neutralize two related proinflammatory activities of pneumolysin, these being the toxinmediated influx of Ca 2ϩ into human neutrophils and Ca 2ϩ -dependent sensitization of these cells for increased production of toxic reactive oxidants (4).Endotoxin-free (Ͻ2 pg/ml) recombinant pneumolysin (specific activity, 4 ϫ 10 6 hemolytic units/mg) was expressed in Escherichia coli and purified from cell extracts as previously described (12).Neutrophils were isolated from heparinized (5 U of preservative-free heparin/ml) venous blood of healthy, adult human volunteers (4) and resuspended to 10 7 neutrophils/ml in phosphate-buffered saline (0.15 M, pH 7.4).cis 7,10,13,16,8,11,14,17-EPA were purchased from Sigma Chemical Co. (St. Louis, Mo.) and made to stock concentrations of 25 mg/ml in ethanol. Dilutions were made in ethanol, and these agents were used at final concentrations of 1.25, 2.5, and 5 g/ml in a final ethanol concentration of 0.1%. All control systems included in the experiments described below contained 0.1% ethanol, which did not interfere with the biological activity of pneumolysin.Fura-2/AM (Sigma) was used as the fluorescent Ca 2ϩ -sensitive indicator to measure alterations in neutrophil cytosolic Ca 2ϩ as previously described (4). The neutrophils were preloaded with fura-2/AM (final concentration, 2 M) for 30 min at 37°C in phosphate-buffered saline, washed, and resuspended in Hanks balanced salt solution (pH 7.4, 1.25 mM CaCl 2 ; Highveld Biological Pty. Ltd., Johannesburg, South Africa). The cells (1 ϫ 10 6 /ml) were then preincubated for 10 min at 37°C with or without DHA or EPA (1.25 to 5 g/ml) and transferred thereafter to cuvettes, maintained at 37°C in a Hitachi 650 10S fluorescence spectrophotometer with e...